Biotech stocks rally on drug innovation and M&A
Moderna gave investors a scare as its stock plunged on Thursday. But it’s still one of the hottest…
Reality of Trump’s drug pricing to set in over next 18 months
Vas Narasimhan, chief executive officer of Novartis AG, during an announcement in the Roosevelt Room of the White…
These 4 charts show the scale of Novo Nordisk’s woes
Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe’s most…
Fed expectedly held rates — Powell’s comments drew interest
Jerome Powell, chairman of the US Federal Reserve, during a news conference following a Federal Open Market Committee…
Roche Shares Rise After Obesity Drug Shows 18% Greater Weight Loss
This article first appeared on GuruFocus. Roche Holding AG (RHHBY) is beginning to show tangible progress in obesity…
Novo Nordisk faces ‘must-win’ battle over U.S. Wegovy, Ozempic in 2026
Still life of the big three injectable prescription weight loss medicines. Ozempic, Victoza and Wegovy. (Photo by: Michael…
Markets could face ‘everything bubble’ as selloff rages on
Global stocks have fluctuated wildly over the past week, as concerns about AI valuations hang over equity markets.…